ISE INDIRECT NA, K, C1 FOR GEN 2— 510(k) K140373

Name: FDA 510(k) clearance K140373
Creator: U.S. Food and Drug Administration
Published: 2014-05-22

Substantially Equivalent

Roche Diagnostics

FDA 510(k) clearance K140373 for ISE INDIRECT NA, K, C1 FOR GEN 2, Substantially Equivalent on 2014-05-22. Applicant: Roche Diagnostics. Device class: 2.

Clearance details

Applicant: Roche Diagnostics
Product code: Code JGS
Device class: Class 2
Regulation: 21 CFR 862.1665
Advisory panel: Clinical Chemistry
Date received: 2014-02-14
Decision date: 2014-05-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Indianapolis, IN, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code JGS

view all

K252475 — ABL90 FLEX PLUS System2026-05-01
K230275 — i-STAT CG8+ cartridge with the i-STAT 1 System2023-10-27
K222438 — A-LYTE® Integrated Multisensor (IMT Na K Cl)2023-07-25
K220977 — ISE Reagents, Glucose, CRP Latex, DxC 500 AU Clinical Chemistry Analyzer2023-07-20
K213486 — GLP systems Track2022-03-10

More clearances from Roche Diagnostics

view all

K261686 — Elecsys Phospho-Tau (217P) Plasma2026-08-19
K252323 — cobas pulse blood glucose monitoring system2026-06-12
K252280 — Elecsys Anti-SARS-CoV-2 S2026-04-13
K260046 — Elecsys Anti-HBc II2026-04-07
K260048 — Elecsys Anti-HAV IgM2026-04-07

Adverse events under product code JGS

product code JGS

Malfunction: 535
Total: 535

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.